|
GENE Genetic Technologies Ltd 1166272 |
| Income Statement |
|
Revenue
|
form6-k
|
7,664,784 |
|
Net Income
|
form6-k
|
-12,017,219 |
|
Profit Margin
|
|
-156.78% |
| Balance Sheet |
|
Current Assets
|
3,695,375 |
|
Assets
|
6,186,521 |
|
Current Liabilities
|
4,195,463 |
|
Liabilities
|
4,356,106 |
|
Equity
|
1,830,415 |
|
Shares Out
|
145,417,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-9,679,048 |
|
Investing Cash Flow
|
114,900 |
| Market Analysis |
Market Cap
|
7,100,348 |
|
Price
|
1676.40 |
|
BVPS
|
0.01 |
|
PB
|
133047.62 |
|
EPS
|
-1.75 |
|
PS
|
0.23 |
|
FCF
|
-9,564,148 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GENE documents filed with the SEC.
GENE Filings
Clear
